Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |